Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART.
<h4>Background and aims</h4>Although combined antiretroviral treatment (cART) has improved overall survival of HIV infected patients, liver fibrosis and liver related-mortality still constitute major challenges in HIV positive patients. Collagen accumulates in the liver during fibrogenes...
Main Authors: | Leona Dold, Mette J Nielsen, Michael Praktiknjo, Carolynne Schwarze-Zander, Christoph Boesecke, Robert Schierwagen, Raphael Mohr, Jan-Christian Wasmuth, Christian Jansen, Jenny Bischoff, Jürgen Kurt Rockstroh, Morten A Karsdal, Ulrich Spengler, Jonel Trebicka, Diana J Leeming |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0219526 |
Similar Items
-
Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients.
by: Evrim Anadol, et al.
Published: (2018-01-01) -
Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
by: Jenny Bischoff, et al.
Published: (2021-10-01) -
Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
by: Leona Dold, et al.
Published: (2017-01-01) -
Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
by: Leona Dold, et al.
Published: (2015-01-01) -
Managing portal hypertension in patients with liver cirrhosis [version 1; referees: 2 approved]
by: Tilman Sauerbruch, et al.
Published: (2018-05-01)